IDEXX Laboratories Inc. (Nasdaq: IDXX), on Tuesday posted fourth-quarter earnings and revenues that exceeded market expectations and gave a bullish outlook for 2021.
The Westbrook-based provider of veterinary diagnostics, veterinary practice software and water microbiology testing posted $2.01 in fourth-quarter earnings per diluted share, an increase of 93% over a year ago.
EPS was also well above the $1.43 consensus forecast of analysts polled by Zacks Investment Research, marking the fourth straight quarter the company has beaten market expectations.
Fourth-quarter revenue was $721 million, or 19% above a year earlier on a reported basis and 17% higher on an organic basis. That exceeded the Zacks consensus forecast by 5.79%.